Tamara Franklin Sells 2,750 Shares of Genpact (NYSE:G) Stock

Key Points

  • Sameer Dewan sold 26,531 shares of Genpact on Nov. 11 at an average price of $44.70, raising about $1.186 million and trimming his holding by 29.76% to 62,617 shares (≈$2.799M).
  • Genpact beat Q3 expectations with $0.97 EPS versus $0.90 expected and $1.29B in revenue versus $1.27B, and issued FY2025 guidance of 3.600–3.610 EPS and Q4 guidance of 0.930–0.940 EPS.
  • The company announced a quarterly dividend of $0.17 per share (annualized $0.68, ≈1.5% yield), and the stock has a consensus analyst rating of Hold with an average target of $51.13 while institutional investors own about 96% of shares.

Genpact Limited (NYSE:G - Get Free Report) Director Tamara Franklin sold 2,750 shares of the stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $45.65, for a total transaction of $125,537.50. Following the completion of the transaction, the director owned 22,236 shares of the company's stock, valued at approximately $1,015,073.40. The trade was a 11.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Genpact Stock Down 0.5%

NYSE:G traded down $0.22 during mid-day trading on Friday, hitting $44.83. 208,700 shares of the company's stock were exchanged, compared to its average volume of 1,709,516. The company has a market cap of $7.73 billion, a PE ratio of 14.46, a P/E/G ratio of 1.45 and a beta of 0.85. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.51 and a quick ratio of 1.53. Genpact Limited has a one year low of $37.49 and a one year high of $56.76. The business has a fifty day moving average price of $41.12 and a 200 day moving average price of $43.28.




Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, November 6th. The business services provider reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.90 by $0.07. Genpact had a net margin of 11.01% and a return on equity of 22.55%. The business had revenue of $1.29 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter last year, the firm earned $0.85 earnings per share. The business's revenue for the quarter was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.600-3.610 EPS. Q4 2025 guidance at 0.930-0.940 EPS. Equities analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Genpact Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Shareholders of record on Tuesday, December 9th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend is Tuesday, December 9th. Genpact's payout ratio is 21.94%.

Institutional Trading of Genpact

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Private Trust Co. NA lifted its holdings in Genpact by 364.2% during the third quarter. Private Trust Co. NA now owns 636 shares of the business services provider's stock valued at $27,000 after purchasing an additional 499 shares in the last quarter. Quent Capital LLC bought a new stake in shares of Genpact during the 3rd quarter valued at $27,000. Westside Investment Management Inc. lifted its stake in shares of Genpact by 193.5% during the 3rd quarter. Westside Investment Management Inc. now owns 678 shares of the business services provider's stock valued at $28,000 after buying an additional 447 shares in the last quarter. iSAM Funds UK Ltd bought a new position in Genpact in the 3rd quarter worth $29,000. Finally, Johnson Financial Group Inc. purchased a new stake in Genpact in the 3rd quarter worth $29,000. 96.03% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Citigroup upgraded Genpact to a "hold" rating in a report on Thursday, October 23rd. Wall Street Zen lowered shares of Genpact from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Deutsche Bank Aktiengesellschaft began coverage on shares of Genpact in a report on Thursday, July 17th. They issued a "hold" rating and a $47.00 target price for the company. JPMorgan Chase & Co. dropped their target price on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 20th. Finally, Needham & Company LLC raised their price target on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Three equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $51.13.

Read Our Latest Research Report on Genpact

About Genpact

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Insider Buying and Selling by Quarter for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Genpact?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Genpact and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles